Literature DB >> 15599394

TB, or not TB: that is the question -- does TLR signaling hold the answer?

Terence M Doherty1, Moshe Arditi.   

Abstract

Innate immunity critically depends on signaling by Toll-like receptors (TLRs) that rely heavily on an intracellular adapter protein called myeloid differentiation factor 88 (MyD88). Adaptive immune defenses are generally thought to be orchestrated by innate immune responses and so should require intact TLR-MyD88 signaling pathways. But a surprising new study in MyD88-null mice infected with Mycobacterium tuberculosis challenges this view and instead suggests that MyD88 may not be absolutely required for a normal adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599394      PMCID: PMC535076          DOI: 10.1172/JCI23867

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

2.  Phagocytosis and the inflammatory response.

Authors:  Alan Aderem
Journal:  J Infect Dis       Date:  2003-06-15       Impact factor: 5.226

Review 3.  The interface between innate and adaptive immunity.

Authors:  Kasper Hoebe; Edith Janssen; Bruce Beutler
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 4.  TLR signaling: an emerging bridge from innate immunity to atherogenesis.

Authors:  Kathrin S Michelsen; Terence M Doherty; Prediman K Shah; Moshe Arditi
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

5.  Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.

Authors:  Carl G Feng; Charles A Scanga; Carmen M Collazo-Custodio; Allen W Cheever; Sara Hieny; Patricia Caspar; Alan Sher
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

6.  A specific gene expression program triggered by Gram-positive bacteria in the cytosol.

Authors:  Ramona L McCaffrey; Paul Fawcett; Mary O'Riordan; Kyung-Dall Lee; Edward A Havell; Patrick O Brown; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

7.  Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.

Authors:  Tsuneyasu Kaisho; Katsuaki Hoshino; Tomio Iwabe; Osamu Takeuchi; Teruhito Yasui; Shizuo Akira
Journal:  Int Immunol       Date:  2002-07       Impact factor: 4.823

8.  Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice.

Authors:  Nengyin Liu; Ruth R Montgomery; Stephen W Barthold; Linda K Bockenstedt
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.

Authors:  Brian Abel; Nathalie Thieblemont; Valerie J F Quesniaux; Najmeeyah Brown; Joseph Mpagi; Kensuke Miyake; Franck Bihl; Bernhard Ryffel
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection.

Authors:  T S Shim; O C Turner; I M Orme
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

View more
  21 in total

Review 1.  Toll-like receptors in innate immunity and infectious diseases.

Authors:  Min-Hao Wu; Ping Zhang; Xi Huang
Journal:  Front Med China       Date:  2010-12-02

Review 2.  The potential of Mycobacterium to protect against allergy and asthma.

Authors:  Charles C Obihara; Jan L L Kimpen; Nulda Beyers
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

3.  Identification of genes associated with susceptibility to Mycobacterium avium ssp. paratuberculosis (Map) tissue infection in Holstein cattle using gene set enrichment analysis-SNP.

Authors:  J N Kiser; M Neupane; S N White; H L Neibergs
Journal:  Mamm Genome       Date:  2017-11-28       Impact factor: 2.957

4.  CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells.

Authors:  Jenny Piercy; Svetla Petrova; Elma Z Tchilian; Peter C L Beverley
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

5.  The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria.

Authors:  Mahesh Yadav; Jeffrey S Schorey
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

6.  Heterozygosity at the A625C polymorphic site of the MyD88 gene is associated with Mycobacterium bovis infection in cattle.

Authors:  Rosanna Capparelli; Francesco De Chiara; Nunzia Nocerino; Chiara Medaglia; Rosa Di Costanzo; Luigi Ramunno; Federico Capuano; Francesco Casalinuovo; Antonio Di Matteo; Domenico Iannelli
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

Review 7.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

8.  Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection.

Authors:  Angela Dolganiuc; Catherine Garcia; Karen Kodys; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

9.  RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.

Authors:  Antje Blumenthal; Toshihiko Kobayashi; Lynda M Pierini; Niaz Banaei; Joel D Ernst; Kensuke Miyake; Sabine Ehrt
Journal:  Cell Host Microbe       Date:  2009-01-22       Impact factor: 21.023

Review 10.  Mycobacterial signaling through toll-like receptors.

Authors:  Joyoti Basu; Dong-Min Shin; Eun-Kyeong Jo
Journal:  Front Cell Infect Microbiol       Date:  2012-11-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.